News: Designer humans vs. Imago Dei: Staying grounded as biotechnology advances.
- Dr. Layne McDonald
- Jun 9
- 5 min read
Immediate Answer: As of June 2026, the push for "designer humans" has shifted from controversial gene editing to a sophisticated "gray market" of embryo selection for non-medical traits like IQ and height. While CRISPR technology offers life-saving cures for genetic diseases, the rise of "techno-eugenics" challenges the biblical truth of Imago Dei: the belief that every human carries inherent, unalterable dignity from God.
What Happened:
In the landscape of 2026, the conversation around biotechnology has reached a fever pitch. For years, the world watched with bated breath as CRISPR-Cas9 moved from a laboratory curiosity to a clinical reality. Today, somatic gene editing: editing the cells of a living person to cure diseases like sickle cell anemia or certain types of blindness: is widely celebrated as a modern medical miracle. These treatments do not affect the patient’s future children, making them a "clean" ethical win for many.
However, a more shadows-drenched frontier has emerged. While international regulations still largely block the creation of "CRISPR babies" (gene-editing embryos), a new commercial sector is flourishing: polygenic embryo screening. Companies are now offering parents the ability to screen IVF embryos not just for devastating diseases, but for "polygenic scores" that predict future intelligence, athletic potential, and physical traits.
Recent reports indicate that startups are charging upwards of $50,000 for these services, ranking embryos by their "predicted success." This shift from editing life to selecting life has created a regulatory vacuum. In the United States, while the FDA remains strict on heritable gene editing, the selection of embryos for non-medical traits remains largely unregulated. This has led to what ethicists call "reproductive tourism" and a growing divide between those who can afford "optimized" offspring and those who cannot.

Both Sides:
The debate over "designer humans" is rarely a simple case of good versus evil. Instead, it is a conflict between two competing visions of human flourishing.
On one side, proponents argue that we have a moral obligation to use every tool at our disposal to reduce suffering. If we can screen out a predisposition for chronic depression, heart disease, or cognitive decline, why shouldn't we? They view the human genome as a "software" that can and should be upgraded. To them, "natural" is not synonymous with "good," and they see biotechnology as the ultimate expression of human agency and love for our children: giving them the "best start" possible.
On the other side, critics and bioethicists warn that we are stepping onto a "slippery slope" toward a new eugenics. They point out that "optimizing" humans turns children into products rather than gifts. If a child is selected for their IQ, what happens to their sense of self-worth if they struggle in school? Furthermore, the social consequences are staggering. If only the wealthy can afford "enhanced" children, we risk creating a permanent biological underclass, where inequality is literally written into our DNA.
This side also highlights the "Brave New World" trap. As discussed in recent bioethical critiques like "Can We Humanize Our Brave New World?", a society that prioritizes the elimination of all struggle and the "perfecting" of the human form often ends up losing its soul. By trying to engineer away our vulnerabilities, we may inadvertently engineer away our capacity for deep empathy, resilience, and genuine love.
Why It Matters:
The "pain" at the heart of this issue is the erosion of what it means to be human. We live in a culture obsessed with performance, optimization, and "living your best life." When this mindset is applied to our very biology, it creates an unbearable pressure.
The promise of biotechnology is a world without pain, but the reality is often a world without peace. We see the pain of parents who feel they are "failing" their children if they don't provide every possible advantage. We see the pain of a society that views disability as a "technical error" rather than a part of the diverse human experience.
When we begin to view human beings as sets of data to be manipulated, we lose sight of the person. We trade the mystery of life for the control of the machine. This "techno-eugenics" doesn't just threaten our DNA; it threatens our community. It tells us that our value is conditional: based on our health, our intelligence, or our utility. In such a world, no one is ever "good enough," because there is always a new "version" of humanity on the horizon.

Biblical Perspective:
The solution to this technological anxiety isn't found in a better algorithm, but in an ancient truth: the Imago Dei.
Genesis 1:27 tells us, "So God created mankind in his own image, in the image of God he created them; male and female he created them." This is the foundational anchor for all human dignity. Our worth is not "engineered" by our parents or "selected" in a lab. Our worth is inherent because we are made by a Creator who calls us "very good."
From a Christ-centered perspective, we see that Jesus did not come to call the "perfected" or the "enhanced." He came for the broken, the weak, and the vulnerable. In the Kingdom of God, the "last shall be first." This stands in direct opposition to a world that wants to select only the "first" and the "best."
Furthermore, the Bible teaches us that suffering and vulnerability are not just "bugs" in the system to be erased. They are often the very places where we encounter the grace of God most deeply. Paul’s "thorn in the flesh" (2 Corinthians 12:9) reminds us that God's power is made perfect in weakness. When we try to design a human life that has no need for God’s grace because it is "sufficiently optimized," we lose the very thing that makes us most alive: our dependence on our Father.
We are called to use medicine to heal (the "Good Samaritan" model), but we must stop short of trying to "be as God" (the "Tower of Babel" model). True peace comes from resting in the fact that we are fearfully and wonderfully made, exactly as we are, in all our beautiful, "imperfect" humanity.

What To Watch Next:
FDA Regulatory Decisions: Look for upcoming rulings on whether polygenic embryo screening for non-medical traits will be classified as a regulated medical procedure.
WHO Global Guidelines: The World Health Organization is expected to release updated ethical frameworks for germline editing later this year, which may influence national laws.
The "Gray Market" Growth: Watch for the emergence of offshore clinics offering "full-spectrum enhancement" packages that bypass Western regulations.
The Church’s Response: As these technologies become more mainstream, expect to see more denominations issuing formal statements on the ethics of genetic selection and the preservation of human dignity.
Follow The McReport for calm, Christ-centered news that seeks truth without cruelty and conviction without contempt.
Which part of your unique, "imperfect" humanity do you feel God is smiling on today?
Sources: AP, Pew Research Center, The Public Discourse, National Institutes of Health (NIH), World Health Organization (WHO).
Comments